Dacia Christin’s Post

Excited to share highlights from the SWOG Latin America Initiative (SLAI) Winter 2024 Newsletter! Strengthening relationships for Latino patients with cancer, we're making strides in international collaboration, tobacco control, and digital health innovations for cancer care. 🔍 Highlights include: - Successful hybrid symposium on tobacco control and its impact on cancer in Latin America. - Record number of SWOG protocols open in Latin America, showcasing our growing impact. - Spotlight on Peru's Instituto Nacional de Enfermedades Neoplásicas (INEN) and their contributions to clinical trials and cancer care. - Innovative research and training initiatives to combat infection-related cancers, with a focus on improving oncology research and patient outcomes globally. 🤝 Our commitment to reducing global cancer disparities and improving patient lives continues to strengthen thanks to our dedicated researchers, partners, and supporters. For more details on our initiatives and achievements, check out the full newsletter #SWOG #CancerResearch #GlobalHealth #Oncology

Excited to share highlights from the SWOG Latin America Initiative (SLAI) Winter 2024 Newsletter! Strengthening relationships for Latino patients with cancer, we're making strides in international collaboration, tobacco control, and digital health innovations for cancer care. 🔍 Highlights include: - Successful hybrid symposium on tobacco control and its impact on cancer in Latin America. - Record number of SWOG protocols open in Latin America, showcasing our growing impact. - Spotlight on Peru's Instituto Nacional de Enfermedades Neoplásicas (INEN) and their contributions to clinical trials and cancer care. - Innovative research and training initiatives to combat infection-related cancers, with a focus on improving oncology research and patient outcomes globally. 🤝 Our commitment to reducing global cancer disparities and improving patient lives continues to strengthen thanks to our dedicated researchers, partners, and supporters. For more details on our initiatives and achievements, check out the full newsletter #SWOG #CancerResearch #GlobalHealth #Oncology

🎥 Join us for this insightful interview with Dr. Ángel R. Nebreda, a leading scientist dedicated to cancer research, ICREA Professor and Group Leader of the Signalling and Cell Cycle Laboratory at IRB Barcelona👇 ✅ Discover how his research laboratory deciphers the ways in which cells interpret external signals to regulate their growth, differentiation, and survival, particularly within tumors. Learn about the pivotal role of the stress-activated p38 MAPK pathway in these processes. ✅ Dr. Nebreda's groundbreaking work has revealed how p38 MAPKs integrate signals, maintain homeostasis, and impact cancer development and progression. Watch the interview here ▶ https://lnkd.in/etcQ4H88 Institució Catalana de Recerca i Estudis Avançats, ICREA ICERCA - Centres de Recerca de Catalunya Barcelona Institute of Science and Technology (BIST) SOMM Alliance Parc Científic de Barcelona #MeetOurScientists #Biomedicine #BreastCancer #Cancer #CancerBiology #CancerResearch #CellSignaling #Chemotherapy #Interview #p38MAPK #Research https://lnkd.in/etcQ4H88

🎥 Join us for this insightful interview with Dr. Ángel R. Nebreda, a leading scientist dedicated to cancer research, ICREA Professor and Group Leader of the Signalling and Cell Cycle Laboratory at IRB Barcelona👇 ✅ Discover how his research laboratory deciphers the ways in which cells interpret external signals to regulate their growth, differentiation, and survival, particularly within tumors. Learn about the pivotal role of the stress-activated p38 MAPK pathway in these processes. ✅ Dr. Nebreda's groundbreaking work has revealed how p38 MAPKs integrate signals, maintain homeostasis, and impact cancer development and progression. Watch the interview here ▶ https://lnkd.in/etcQ4H88 Institució Catalana de Recerca i Estudis Avançats, ICREA ICERCA - Centres de Recerca de Catalunya Barcelona Institute of Science and Technology (BIST) SOMM Alliance Parc Científic de Barcelona #MeetOurScientists #Biomedicine #BreastCancer #Cancer #CancerBiology #CancerResearch #CellSignaling #Chemotherapy #Interview #p38MAPK #Research

Welcome to the Caring and Sharing Advanced Oncology podcast. The host Uta Schmidt-Straßburger was joined again by Joe Lennerz, a board-certified pathologist and the chief scientific officer at BostonGene. Two notable papers from BostonGene scientists are being discussed, featured on the covers of Cancer Cell and Gastroenterology. These papers delve into tumor sample profiling, introducing new classification methods. Starting with the Cancer Cell paper, Dr. Lennerz explained their advanced immunoprofiling assay from blood, which uses high-complexity techniques to provide a comprehensive "immune system count" of over 300 markers. This approach identifies five distinct immunotypes, aiding in predicting responses to immunotherapy, particularly in cancers like head and neck squamous cell carcinoma. Next, the Gastroenterology paper with a focus on pancreatic ductal adenocarcinoma (PDAC) was explored. By analyzing transcriptomic data from over 1600 patients, the team identified four microenvironment subtypes with significant prognostic implications. These findings could lead to better stratification and treatment approaches for this aggressive cancer. Dr. Lennerz emphasized the potential of these classifications in clinical trials and personalized treatment plans, highlighting the innovative strides in oncology research. Tune in to learn more about these groundbreaking studies and their impact on cancer treatment. YouTube https://lnkd.in/e9SzHWhV Spotify https://lnkd.in/e-NRYbsC Cancer Cell paper https://lnkd.in/e5zuJFgJ Gastroenterology paper https://lnkd.in/ecgyyDkH #Oncology #CancerResearch #Immunotherapy #CancerTreatment #TumorProfiling #Pathology #CancerScience #MedicalPodcast #OncologyPodcast #CancerCare #CancerCell #Gastroenterology #PancreaticCancer #Immunoprofiling #ClinicalTrials #PrecisionMedicine #CancerAwareness #HealthcareInnovation #MedicalResearch #SciencePodcast #BostonGene #CancerBreakthroughs #TumorMicroenvironment #CancerStudies #MedicalScience #CancerDiagnosis #CancerTherapy #AdvancedOncology #CancerSurvival #CancerBiomarkers

"I truly believe that it's a privilege to be here at Northwestern and to be able to take care of each patient I interact with at a very difficult time during their journey with a cancer #diagnosis,"-Tarita Thomas MD, PhD. Meet Dr. Thomas, an MBTI #RadiationOncologist, in this video: https://lnkd.in/gY7ftFbT. #BTSM #RadOnc #BrainCancer #Oncology

The results are in from the CML Survey on Unmet needs and the findings have identified a lack of communication between CML patients and their doctors when it came to treatment goals and roles in decision-making. Here's a snaphot of what two leading CML specialists had to say about the results. Novartis CML Advocates Network CML Buster Foundation a 501(c)(3) #CML #communication #livedexperience #treatmentgoals #cancer https://lnkd.in/gsEUkc2h

Schedule a meeting with the experts from Discovery Life Sciences at #ASCO24

After the changes in #GDPR, the possibility of fostering scientific data on the outcome of #cardiothoracictrasplantation and #MCS has been slowed down everywhere. The need to unify data management on a #European and #Global basis should represent a European priority for accelerating the collection of knowledge and reducing the #inequities. Join #ESOTaction. #ECTTA_ESOT

📢 In case you missed it! Don't forget to check out MedNews Week's most recent Keynote Speaker, 🌟Dr. Ann LaCasce🌟 of the Dana-Farber Cancer Institute – as she discusses the latest updates in Hodgkin's Lymphoma. It was a pleasure to learn from her! Event link:  https://lnkd.in/gCYkxiAf Accomplishments:  🌎Internationally Recognized leader in Hematological Malignancies and Treatment 👨🔬director of the advanced fellowship in Hematologic Malignancies  🏆recipient of multiple prestigious awards such as: -Regional Top Doctor in Castle Connolly  -medical Oncology education Award of DFCI -Institutional citizenship award at DFCI 🎓passionate mentor to students in all levels of training Yan Leyfman, MD Maduri Balasubramanian Sean Jackewicz Shreevikaa Kannan Soumiya Nadar Rabab Hunaid Abbas Emad Bin Zahid Ahmed Hashim Azeez Vallabhaneni Sree Harshitha Muskan Joshi  Helena Sanchez Coloma Alexandra Van de Kieft Harshal C. Gayathri Pramil Menon Fabiha Amin Adhith Theyver #HodgkinLymphoma #HodgkinDisease #HodgkinCancer #HodgkinAwareness #HodgkinWarrior #HodgkinFight #HodgkinStrong #BeatHodgkin #LymphomaAwareness #CancerSurvivor  #Lymphoma #LymphomaAwareness  #BloodCancer #CancerAwareness  #FightLymphoma #LymphomaSupport #LymphomaWarrior #BeatLymphoma #CancerSurvivor #CancerResearch #Hematology #Hematologist #BloodDisorders #BloodResearch #BloodHealth #HematologyAwareness #HematologyEducation #BloodScience #HematologyConference #HematologyNews #cancer #cancersucks #cancermemes #cancersurvivor #cancerawareness #cancerousmemes #cancerous #cancerresearch #cancerfree #cancerfighter #cancerwarrior #cancermeme #cancersupport #cancerprevention #cancersurvivors #cancers #cancercare #cancerresearchuk #cancerawarenessmonth #oncology #immunology #immunotherapy #genetherapy #cancer #cancerawareness #cancerresearch #oncologist #oncología #oncologyresearch #clinicaltrial #clinicalresearch #oncology #immunology #immunotherapy #genetherapy #cancer #cancerawareness #cancerresearch #medicine #research